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Abstract 
Background: Cyanobacterium Synechococcus elongatus PCC 7942 holds promise for biochemical conversion, but 
gene deletion in PCC 7942 is time‑consuming and may be lethal to cells. CRISPR interference (CRISPRi) is an emerging 
technology that exploits the catalytically inactive Cas9 (dCas9) and single guide RNA (sgRNA) to repress sequence‑
specific genes without the need of gene knockout, and is repurposed to rewire metabolic networks in various pro‑
caryotic cells.
Results: To employ CRISPRi for the manipulation of gene network in PCC 7942, we integrated the cassettes express‑
ing enhanced yellow fluorescent protein (EYFP), dCas9 and sgRNA targeting different regions on eyfp into the PCC 
7942 chromosome. Co‑expression of dCas9 and sgRNA conferred effective and stable suppression of EYFP produc‑
tion at efficiencies exceeding 99%, without impairing cell growth. We next integrated the dCas9 and sgRNA targeting 
endogenous genes essential for glycogen accumulation (glgc) and succinate conversion to fumarate (sdhA and sdhB). 
Transcription levels of glgc, sdhA and sdhB were effectively suppressed with efficiencies depending on the sgRNA 
binding site. Targeted suppression of glgc reduced the expression to 6.2%, attenuated the glycogen accumulation to 
4.8% and significantly enhanced the succinate titer. Targeting sdhA or sdhB also effectively downregulated the gene 
expression and enhanced the succinate titer ≈12.5‑fold to ≈0.58–0.63 mg/L.
Conclusions: These data demonstrated that CRISPRi‑mediated gene suppression allowed for re‑directing the cellular 
carbon flow, thus paving a new avenue to rationally fine‑tune the metabolic pathways in PCC 7942 for the production 
of biotechnological products.
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Background
Cyanobacteria are photoautotrophic procaryotes that 
can exploit sunlight and CO2 as the sole energy and car-
bon sources to convert CO2 into organic compounds 
via photosynthesis [1]. Many cyanobacterial strains are 
amenable to natural transformation and homologous 
recombination for gene manipulation. Thanks to these 
attributes, genetically engineered cyanobacteria have 
drawn increasing attention as a chassis for the production 
of biofuels and bio-derived chemicals [2]. For instance, 
Synechococcus elongatus PCC 7942 has been genetically 
modified as a “cell factory” to divert native metabolic 
pathways to produce 2,3-butanediol, 2-methyl-1-butanol, 
isopropanol, free fatty acid, 1,2-propanediol, isopropanol, 
isobutyraldehyde and isobutanol, etc. [3].
Typically, PCC 7942 is engineered by knocking in genes 
encoding synthetic pathways and/or knocking out genes 
in competing pathways [4, 5]. However, generation of a 
single gene knockout mutant may take  >3  weeks using 
conventional methods [6] due to its long doubling time 
and oligoploidy nature [1]. Sometimes deletion of cer-
tain genes essential for metabolic balances is not feasible 
or easily achieved as the deletion might be lethal to the 
cells. Furthermore, in many cases intermediate levels of 
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enzyme expression may result in better product titer [7]. 
Therefore, tunable and balanced gene expression is desir-
able for high productivity, product titer, and conversion 
yield, and controllable gene repression/knockdown may 
be preferable than gene deletion for certain biotechno-
logical applications and synthetic biological manipula-
tions [8].
CRISPR-Cas9 is a newly developed RNA-guided 
genome editing system [9, 10]. CRISPR-Cas9 system 
comprises the Cas9 nuclease, transacting RNA (tracr-
RNA) and CRISPR RNA (crRNA). crRNA/tracrRNA 
complexes with Cas9 and, guided by the spacer sequence 
on crRNA, orchestrate to recognize protospacer-adja-
cent motif (PAM) and bind to proximal complemen-
tary sequence. After the recognition and binding, Cas9 
nuclease triggers double strand break (DSB) at the chro-
mosomal DNA [11]. Coupled with an editing template 
DNA, such CRISPR-Cas9-mediated DSB is exploited for 
programmable genome engineering of diverse cell types 
and model organisms [12–16], as well as for gene and cell 
therapy [17–19]. We have also employed CRISPR to engi-
neer the PCC 7942 genome [20] and effectively inserted 
DNA fragments as large as 7  kb into Escherichia coli 
genome [21].
Furthermore, the catalytic domains of Cas9 are 
mutated to generate the inactive Cas9 (dCas9) lacking 
the endonuclease activity. dCas9 is used in conjunction 
with the chimeric single guide RNA (sgRNA) wherein the 
mature crRNA is fused to a partial tracrRNA to mimic 
the natural crRNA:tracrRNA duplex. By co-expression, 
the dCas9-sgRNA complex specifically binds to the tar-
get gene at the promoter or coding sequence and acts as 
a roadblock to the elongating RNA polymerase, hence 
aborting transcription initiation or elongation [22]. This 
new technology, termed CRISPR interference (CRISPRi), 
was recently repurposed to repress sequence-specific 
genes in diverse eucaryotic and procaryotic cells, for 
rewiring metabolic networks [23, 24] and high-through-
put interrogation of genome-wide gene functions [25, 
26]. Very recently, CRISPRi has also exploited for gene 
regulation in cyanobacteria Synechcocystis sp. PCC 6803 
[27] and Synechococcus sp. PCC 7002 [7]. However, 
whether CRISPRi functions in PCC 7942 has yet to be 
explored.
In this study, we harnessed the CRISPRi system to 
effectively knockdown exogenous and endogenous genes 
in PCC 7942 via appropriate sgRNA design. Selective 
repression of glgc, sdhA and sdhB genes increased the 
succinate production by PCC 7942, hence demonstrating 
the feasibility of employing CRISPRi for the metabolic 




All molecular cloning experiments were performed using 
E. coli DH5α strain (Sigma). Unless otherwise noted, for 
suspension culture S. elongatus PCC 7942 (Invitrogen) 
was cultivated in a 250 ml shake flask containing 40 ml 
BG-11 medium [4, 5] with or without antibiotics (gyra-
tory shaking at 100 rpm, with sterile air containing 0.04% 
CO2) in a 30  °C incubator (600SR, Hipoint) with illu-
mination from continuous cool white fluorescent light 
(intensity ≈ 70 μmol//m2 s). For solid culture, PCC 7942 
cells were streaked onto 90 mm plates containing 40 cm3 
BG-11/agar medium supplemented with 1  mM sodium 
thiosulfate and appropriate antibiotic, and incubated 
with continuous illumination (intensity 70  µmol//m2  s) 
for 7–9 days until colonies developed.
Plasmids construction
pdCas9-bacteria plasmid (Addgene #44249) harbored 
chloramphenicol resistance gene (CmR) and dCas9 gene 
(derived from S. pyogenes) driven by the PLtetO1 pro-
moter [24]. The sequences homologous to the 5′ (5-NSI) 
and 3′ (3-NSI) end of PCC 7942 NSI site (neutral site I), 
together with the intervening origin of replication (ori), 
were PCR-amplified from pSYN_1 plasmid (Invitro-
gen) with flanking AvrII and SpeI sites. pdCas9-bacte-
ria and the PCR product were separately digested with 
AvrII/SpeI and ligated together (Additional file 1: Figure 
S1). The resultant pLtetO1-dCas9 contained the CmR and 
PLtetO1-dCas9 expression cassettes flanked by the 5-NSI 
and 3-NSI homology arms (Additional file 1: Figure S1).
We next PCR-amplified the Psmt promoter (including 
the promoter smtA and the repressor smtB) from the 
PCC 7942 chromosome, which was cloned into pLtetO1-
dCas9 by AflII/BglII digestion to replace the PLtetO1 pro-
moter, yielding pSdCas9 (Additional file  1: Figure S2). 
The eyfp gene under the control of PconII promoter was 
PCR-amplified from pconII-EYFP’ (see Additional file 1: 
Supplementary Methods) and subcloned into pSdCas9 
by AvrII/SmaI (Additional file 1: Figure S3). The resultant 
pSdCas9-CY’ harbored the expression cassettes compris-
ing CmR, dCas9 under Psmt and eyfp under PconII, which 
were flanked by homology arms targeting the NSI site 
(5-NSI and 3-NSI).
pgRNA-bacteria plasmid (Addgene, #44251) contained 
the ampicillin-resistance gene (ApR) and an sgRNA back-
bone driven by PJ23119 promoter. The sgRNA backbone 
comprised the base-pairing (spacer) region (20  bp), 
dCas9 handle (42  bp) and the S. pyogenes terminator 
(40 bp) as described [22]. To replace the spacer sequence 
on the sgRNA backbone with new spacer sequences tar-
geting different regions on the PCC 7942 chromosome, 
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we designed a reverse primer Ec_R and forward primers 
Ec_F with different new spacer sequences (Table 1), and 
performed inverse PCR (iPCR) using pgRNA-bacteria as 
the template [22]. The resultant PCR products compris-
ing the new sgRNA sequences, ApR and PJ23119 promoter 
were phosphorylated using T4 polynucleotide kinase and 
joined using T4 DNA ligase to form new plasmids (bac-
teria sgRNA plasmids) containing sgRNA targeting dif-
ferent regions on the PCC 7942 chromosome (Additional 
file 1: Figure S4A).
To integrate the sgRNA sequences into NSII (neutral 
site II) site, the sequences homologous to the 5′ (5-NSII) 
and 3′ (3-NSII) end of PCC 7942 NSII site were PCR-
amplified from pNSII_plus plasmid (kindly provided by 
Prof. James Liao). The resultant PCR product consisted 
of 5-NSII, origin of replication (ColE1), 3-NSII and kan-
amycin resistance gene (KmR). The PCR product and 
bacteria sgRNA plasmid were digested by EcoRI/BamHI 
and ligated to form the psgRNA plasmids as shown in 
Additional file 1: Figure S4B. The resultant plasmids were 
designated as psgRNA::Φ, psgRNA::P1, psgRNA::NT1, 
psgRNA::NT2, psgRNA::glgc1, psgRNA::glgc2, psgRNA:: 
sdhA1, psgRNA::sdhA2, psgRNA::sdhB1 or psgRNA:: 
sdhB2, depending on the target gene and location (see 
“Results” section).
Transformation and recombinant cell construction
For transformation into PCC 7942, 40  ml cells in the 
shake flask were cultured to optical density at 730  nm 
(OD730)  =  0.6–0.8, centrifuged (5000×g for 15  min), 
washed with 20  ml BG-11 medium, centrifuged 
again, resuspended in 2  ml BG-11 medium and ali-
quoted (300  µl per microfuge tube). The plasmids were 
quantified using Nanodrop 2000 (Thermo), and 2000 ng 
plasmid was added to the tubes and mixed well with the 
aliquoted cells. The tubes were wrapped with foil and 
incubated with the rotary mixer in the incubator (30 °C) 
for 24  h to enhance the transformation efficiency as 
described [28]. The transformed cells were streaked onto 
the BG-11/agar plate containing appropriate antibiotics 
(e.g. 5  µg/ml Cm and 10  µg/ml Km) and cultured until 
colonies developed. The colonies were re-streaked twice 
onto the BG-11/agar plate containing antibiotics to yield 
the recombinant cells.
Growth curve, flow cytometry and confocal microscopy
The recombinant cells were transferred to and cultured 
in the shake flask containing Cm/Km. In parallel, wild-
type (WT) cells were cultured in the same fashion with-
out antibiotics. One milliliter of cells were sampled daily 
for the measurement of OD730 for the growth curve. The 
cells (1  ml) were also withdrawn every 3  days for EYFP 
analysis, followed by replenishment with 4  ml fresh 
BG-11 medium with or without antibiotics.
For eyfp expression analysis, the cells were subjected 
to flow cytometry (FACSCalibur, BD Biosciences) and 
the mean fluorescence intensity (FI) of 10,000 cells was 
measured. The mean FI (in arbitrary unit, a.u.) of each 
group was subtracted from that of WT cells to yield the 
final mean FI.
Alternatively, the eyfp-expressing recombinant cells 
were cultured in the shake flask to mid-log phase 
(OD730  =  1–1.5), and the cells were subjected to flow 
cytometry analysis or observed at 1000× under a confo-
cal microscope (Eclipse TE2000-E, Nikon) for the yellow 
fluorescence (488 nm) and auto fluorescence (543 nm).
Table 1 Primer sequences for psgRNA plasmid construction
The spacer sequences are underlined
Primers Sequence (5′–3′)
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Quantification of mRNA by qRT‑PCR
PCC 7942 cells were cultured in 40  ml BG-11 medium 
with or without antibiotics to OD730 = 0.7–1.3 and 5 ml 
cells were centrifuged (17,000×g for 5  min) and stored 
at −80 °C. After thawing, total RNA was extracted using 
NucleoSpin® RNAIIKit (Macherey Acherey-Nagel) with 
minor modifications to increase the extraction efficiency: 
the lysozyme concentration was increased to 2  mg/ml 
and reaction time at 37 °C was extended to 20 min. The 
extracted mRNA was quantified using a spectropho-
tometer (Nanodrop 2000, Thermo) and 1  µg RNA was 
reverse-transcribed to cDNA using the MMLV Reverse 
Transcription 1st-strand cDNA Synthesis Kit (Epicentre 
Biotechnologies). The cDNA was diluted in 1 ml deion-
ized water and stored at −20  °C. After thawing, 3  µl 
cDNA was mixed with 1.5 µl deionized water, 0.5 µl gene-
specific primer pairs (10 µM, Table S1) and 5 µl SYBR® 
Green PCR Master Mix (Applied Biosystems). Subse-
quent quantitative real-time PCR (qPCR) was performed 
using StepOnePlus™ (Applied Biosystems) with the PCC 
7942 housekeeping gene rnpB as the internal control 
[29]. Gene expression levels in all groups were normal-
ized to those in the WT control group.
Glycogen analysis
Because PCC 7942 accumulates glycogen under nitro-
gen starvation conditions [30], we cultured cells in 
nitrate-deplete (0×N) BG-11 medium (which is similar 
to BG-11 medium except that NaNO3 was not included) 
to force cells to accumulate glycogen. Recombinant PCC 
7942 cells cultured in shake flasks to mid-log phase 
(OD730 ≈  0.7–1.3) were centrifuged (25  °C, 6000×g for 
20  min), resuspended in 20  ml nitrate-deplete (0×N) 
BG-11 medium, centrifuged again, resuspended in 40 ml 
nitrate-deplete BG-11 medium containing Km/Cm, and 
cultured for 2 more days. As a control, WT cells were 
cultured and washed in a similar fashion, and cultured in 
nitrate-deplete, antibiotic-free BG-11 medium for 2 more 
days.
The cell density was adjusted to OD730 =  1 and 1  ml 
of cells were centrifuged (17,000×g for 5 min), followed 
by resuspension in 1  ml deionized water and homog-
enization using Bead Beater (Kelowna). After centrifuga-
tion (17,000×g, 5 min), the glycogen content (µg) in the 
supernatant was analyzed using the Glycogen Colorimet-
ric/Fluorometric Assay Kit (Biovision, k646-100).
Succinate analysis
Recombinant PCC 7942 cells cultured in the shake flasks 
to stationary phase (OD730  ≈  2.0) were centrifuged 
(25  °C, 6000×g for 20  min), and resuspended in 20  ml 
nitrate-deplete (0×N) BG-11 medium. After centrifuga-
tion, the cells were resuspended in 40 ml nitrate-deplete 
BG-11 medium containing Km/Cm and cultured in the 
shake flasks.
As a control, WT PCC 7942 cells were cultured in 
80 ml BG-11 medium to OD730 ≈ 2.0, divided in half into 
50  ml tubes, washed twice by centrifugation (6000×g, 
20 min) and resuspension in 40 ml complete or nitrate-
deplete BG-11 medium, followed by shake flask culture 
using 40  ml complete (1×N) or nitrate-deplete (0×N) 
BG-11 medium.
After 2 days, 1.5 ml recombinant or WT cells were col-
lected, filtered through 0.22 µm and the supernatant was 
analyzed by UFLC-MS (LCMS-2020, Shimadzu) with a 
column [Acclaim™ Organic Acid, 3  µm, 2.1 ×  150  mm 
(Dionex)] for the succinic acid titer (mg/l).
Statistical analysis
All quantitative data were analyzed using student’s t test. 
All data represent the averages of at least 3 independent 
culture experiments. p < 0.05 was considered significant.
Results
Pre‑test of promoters for gene expression in S. elongatus 
PCC 7942
Although a number of inducible promoters (e.g. high-
light-responsive psbA promoter, copper-regulated petE 
promoter, nitrate/nitrite-inducible PnirA promoter and 
the nickel-regulated nrsA promoter) have been assessed 
in cyanobacteria, induction of these regulatory systems 
could concurrently affect the endogenous cognate regu-
lon and result in unwanted effects [1, 31, 32]. To evalu-
ate appropriate promoters useful for driving CRISPRi 
in PCC 7942, we compared different inducible promot-
ers (Psmt, PLtetO1, PConII-ribo, Ptrc, PLlacO1 and PBAD) derived 
from E. coli or cyanobacteria (Additional file  1: Figure 
S5). We determined that Psmt gave the highest enhanced 
yellow fluorescent protein (EYFP) expression and the 
highest induction ratio in PCC 7942 (Additional file  1: 
Figure S6). We next assessed various constitutive pro-
moters (Ptrc’, PLlacO1′, PconII, PJ23101 and PJ23119, Additional 
file  1: Figure S7) and determined that PconII and PJ23119 
gave rise to the highest eyfp expression levels (Additional 
file 1: Figure S8).
Establishment of CRISPRi system in PCC 7942
In light of aforementioned data, these 3 promoters were 
chosen for subsequent establishment of CRISPRi sys-
tem in PCC 7942. We constructed pSdCas9-CY’ with 
the expression cassette comprised of chloramphenicol 
resistance gene (CmR), dCas9 under Psmt, and eyfp under 
PconII, which was flanked by homology arms targeting 
the NSI site (Fig. 1a). In parallel, we constructed a series 
of psgRNA plasmids harboring the cassette expressing 
kanamycin resistance gene (KmR) and sgRNA under the 
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PJ23119 promoter, which was flanked by NSII-targeting 
homology arms (upper panel, Fig. 1b). The sgRNA were 
designed to target the eyfp cassette at the non-template 
strand of promoter (P1) or coding regions near the tran-
scription start site (NT1) or near the middle of gene 
(NT2) so that the fluorescence intensity served as the 
indicator of gene repression (lower panel, Fig.  1b). We 
transformed pSdCas9-CY’ into PCC 7942 for cassette 
integration into NSI site, re-streaked, and then trans-
formed individual psgRNA into the recombinant cells for 
integration into NSII site (Additional file  1: Figure S9), 
yielding recombinant clones expressing EYFP, dCas9 and 
different sgRNA (dCas9::P1, dCas9::NT1 or dCas9::NT2). 
As controls, we also constructed cells that expressed (1) 
only EYFP and the sgRNA targeting P1 (P1 group); (2) 
dCas9 and EYFP (dCas9 group) and (3) dCas9, EYFP 
and a scramble sgRNA (dCas9::Φ group). The cells were 
streaked onto BG-11/agar plates containing Km/Cm for 
7–9 days, and resistant (KmR/CmR) colonies were picked 
for colony PCR to verify correct integration (data not 
shown). The colonies were transferred to shake flasks and 
cultured to OD730 = 1–1.5 in BG-11 medium containing 
appropriate antibiotics.
The fluorescence micrographs (Fig. 1c) showed that all 
groups had similar auto-fluorescence and the 3 control 
groups (P1, dCas9 and dCas9::Φ) lacking complete func-
tional dCas9/sgRNA complex exhibited similar EYFP 
expression. In contrast, EYFP expression was diminished 
in the 3 experimental groups (dCas9::P1, dCas9::NT1 and 
dCas9::NT2) expressing both dCas9 and sgRNA (Fig. 1c). 
The flow cytometry analysis (Fig.  1d) further depicted 
that EYFP expression in the dCas9::P1, dCas9::NT1 and 
dCas9::NT2 was suppressed to ≈4.5, ≈0.9 and ≈24.0% 
that of the control dCas9::Φ group, respectively. These 
data confirmed the successful establishment of CRISPRi 
system that effectively repressed gene expression for up 
to ≈111-fold in PCC 7942. It is noteworthy that dCas9 
was driven by an inducible promoter Psmt which could 
be induced with ZnSO4. However, even without inducer, 
the EYFP repression was still very effective (Fig. 1c), sug-
gesting that a low basal level of dCas9 expression was suf-
ficient to mediate the gene suppression. Therefore, the 
inducer was not added in all subsequent experiments.
Effect of CRISPRi on PCC 7942 growth and persistent 
transgene repression
To examine whether CRISPRi conferred long-term, sta-
ble gene suppression and imposed toxicity, the KmR/CmR 
colonies of all groups were transferred to shake flasks 
and cultured in 40  ml BG-11 medium containing Km/
Cm. As a control, wild-type (WT) cells were cultured in 
40 ml BG-11 without antibiotics. The cells were cultured 
for 21 days, during which cells were sampled for OD730 or 
flow cytometry analysis. As judged from the flow cytome-
try analysis (Fig. 2a), dCas9::Φ continued to express EYFP 
throughout the experiment, whereas the EYFP expression 
in the dCas9::P1, dCas9::NT1 and dCas9::NT2 groups 
remained suppressed for 21  days, proving that CRIS-
PRi was able to persistently knockdown gene expression 
in PCC 7942. Meanwhile, all groups, including the WT 
control, had virtually overlapped growth curves (p > 0.05, 
Fig.  2b), indicating that dCas9 expression and persistent 
sgRNA expression did not affect the cell growth.
CRISPRi‑mediated suppression of endogenous genes
Cyanobacteria can accumulate glycogen as a carbon sink 
under nitrogen starvation conditions. Deleting the glgc gene 
can abolish glycogen synthesis [33, 34] because glgc gene 
product is a key enzyme in the glycogen synthesis pathway. 
Conversely, sdhA and sdhB gene products are responsible 
for converting succinate to fumarate in the TCA cycle.
To evaluate the ability of CRISPRi to suppress endog-
enous genes, we constructed pSdCas9 that expressed 
dCas9 under Psmt and a new series of psgRNA that 
targeted no sequences on the genome of PCC 7942 
(psgRNA::Φ) or different coding regions of glgc, sdhA and 
sdhB genes (Fig.  3a). PCC 7942 cells were transformed 
with pSdCas9 first for integration into NSI site, and were 
transformed again with individual psgRNA plasmids for 
integration into NSII site. The KmR/CmR colonies were 
transferred to shake flasks and cultured to OD730 = 0.7–
1.3, and 5 ml cells were sampled for mRNA analysis.
The qRT-PCR analysis (Fig.  4a–c), using the expres-
sion in WT cells as the basis, showed that the scram-
ble sgRNA (Φ) did not significantly (p > 0.05) affect the 
expression of glgc, sdhA or sdhB. In contrast, the sgRNA 
targeting the non-template coding regions of glgc (glgc1 
(See figure on next page.) 
Fig. 1 Establishment of CRISPRi in PCC 7942. a Map of pSdCas9‑CY’ harboring CmR, dCas9 under Psmt and eyfp under PconII, which was flanked by 
homology arms targeting the NSI site. Trrnb, transcriptional terminator. Psmt consists of the smtA promoter and the smtB repressor. b Map of psgRNA 
harboring the cassette expressing KmR and sgRNA under the PJ23119 promoter, which was flanked by NSII‑targeting homology arms. The sgRNAs 
were designed to target no sequence on the PCC 7942 chromosome (Φ) or the eyfp cassette at the non‑template strand of promoter (P1) or coding 
regions near the transcription start site (NT1 and NT2). The numbers indicate the position relative to the transcription start site. c Confocal micro‑
graphs of cells. d Flow cytometry analysis data. pSdCas9‑CY’ was first transformed into PCC 7942 for cassette integration into NSI site, re‑streaked, 
then individual psgRNA was transformed into the recombinant cells for integration into NSII site. The transformants colonies were transferred to 
shake flasks and cultured to OD730 = 1–1.5 in BG‑11 medium containing appropriate antibiotics
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and glgc2) attenuated the glgc expression to ≈6.2 and 
≈26.6%, respectively (Fig. 4a), which represented ≈16.1- 
and ≈3.8-fold repression, respectively. The sgRNA tar-
geting sdhA (sdhA1 and sdhA2) and sdhB (sdhB1 and 
sdhB2) mitigated the expression to ≈18.9, ≈71.2, ≈33.1 
and ≈36.6%, respectively (Fig.  4b, c). We also designed 
sgRNA targeting further downstream of the coding 
regions and found poorer repression efficiency (data not 
shown). These data attested that CRISPRi effectively sup-
pressed the endogenous gene expression, and the silenc-
ing efficacy was inversely correlated with the distance of 
target region from the transcription start site.
CRISPRi‑mediated gene downregulation enhanced the 
production of chemicals
To evaluate the effect of repressing glgc, sdhA or sdhB 
genes, KmR/CmR cells were cultured to OD730 ≈  0.7–
1.3, centrifuged and cultured in shake flasks containing 
40  ml nitrogen-deplete BG-11 (BG-11 devoid of 
NaNO3) for 2  days. Under nitrogen starvation condi-
tions, suppression of glgc gene concomitantly miti-
gated the glycogen accumulation to ≈4.8% (glgc 1 
group) and 25.5% (glgc2 group) that of the WT group 
(Fig.  5a), but did not induce chlorosis (a condition in 
which cells produce insufficient  chlorophyll, data not 
shown). We also attempted to target other non-tem-
plate coding regions of glgc further far away from the 
start codon than glgc1 and glgc2, which attenuated 
glycogen accumulation with varying degrees (from 37 
to 72%, data not shown).
Moreover, we examined the succinate production by 
individually targeting the aforementioned gene regions 
and compared the succinate levels with those of the 
non-targeting control (Φ group) and WT groups under 
nitrate-replete (1×N) and nitrate-deplete (0×N) condi-
tions (nitrogen-deplete BG-11 medium). Figure 5b delin-
eates that WT cells cultured with nitrogen (1×N) did 
not produce appreciable amounts of succinate, yet pro-
duced slightly more succinate (≈0.05 mg/L) under nitro-
gen starvation (0×N) conditions. Repression with glgc1, 
sdhA1, sdhB1 and sdhB2 led to significantly elevated suc-
cinate titer when compared with WT cells and the cells 
without CRISPRi suppression (Φ group), reaching ≈0.26, 
≈0.61, ≈0.58 and ≈0.63 mg/L, respectively (Fig. 5b). By 
suppressing sdhA or sdhB, the succinate titer (≈0.58–
0.63  mg/L) was ≈12.5-fold higher than that in the WT 
cells. These data collectively confirmed that CRISPRi was 
able to suppress endogenous genes and enhanced succi-
nate production in PCC 7942.
Fig. 2 Effect of CRISPRi on PCC 7942 growth and persistent 
transgene repression. a Mean fluorescence intensity (FI) profiles. b 
Growth curves. The recombinant cells were cultured in 40 ml BG‑11 
medium containing Km/Cm. Wild‑type (WT) cells were cultured in 
40 ml BG‑11 without antibiotics. The cells were cultured for 21 days, 
during which cells were sampled for OD730 or flow cytometry analysis
Fig. 3 Schematic illustration of plasmids used for CRISPRi‑mediated 
suppression of glgc, sdhA and sdhB. Φ indicates the scramble sgRNA. 
Glgc1, glgc2, sdhA1, sdhA2, sdhB1 and sdhB2 are the sgRNA target‑
ing different regions of endogenous genes. pSdCas9 expressed dCas9 
under Psmt
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Discussion
CRISPRi holds great promise for a wide range of applica-
tions in microorganisms, including bacterial cell growth 
control [35], genetic screen [25, 36], synthetic biology 
module development [37, 38] or metabolic networks 
control in various microorganisms such as E. coli [24, 39, 
40], mycobacteria [41], Bacillus subtilis [42], Corynebac-
terium glutamicum [43], Clostridium beijerinckii [44], 
yeast [45] and cyanobacteria [7]. In particular, a number 
of recent studies have exploited CRISPRi to regulate the 
metabolic pathways in E. coli for enhanced production 
of various biotechnological products including poly(3-
hydroxybutyrate-co-4-hydroxybutyrate) [23], terpenoid 
[8], pinosylvin [46], flavonoid [47] and mevalonate [48]. 
Escherichia coli is a popular host as it has been exten-
sively studied, grows fast, possesses a single chromo-
some and plenty of genetic engineering toolkits have 
been developed for E. coli engineering. Furthermore, 
E. coli allows the replication and continued presence of 
plasmids within the cells, which renders easy establish-
ment and maintenance of CRISPRi elements (dCas9 and 
sgRNA) in E. coli.
In contrast, cyanobacteria grow relatively slowly and 
current knowledge and synthetic biology tool devel-
opment for cyanobacteria lag far behind those for E. 
coli [49]. Furthermore, many cyanobacteria possess 
Fig. 4 Effective suppression of endogenous genes by CRISPRi. a glgc expression. b sdhA expression. c sdhB expression. PCC 7942 cells were trans‑
formed with pSdCas9 first for integration into NSI site, and were transformed again with individual psgRNA plasmids for integration into NSII site. 
The KmR/CmR colonies were transferred to 40 ml BG‑11 medium containing Km/Cm and cultured to OD730 = 0.7–1.3, and 5 ml cells were sampled 
for qRT‑PCR analysis. The expression levels were normalized to those in the WT cells
Fig. 5 Effects of CRISPRi‑mediated suppression on glycogen accumulation and succinate production. a Glycogen titer (µg/OD730). b Succinate titer 
(mg/l). For glycogen analysis, KmR/CmR cells were cultured to OD730 ≈ 0.7–1.3, centrifuged and cultured in shake flasks containing 40 ml nitrogen‑
deplete (0×N) BG‑11 for 2 days and subjected to glycogen analysis. To analyze succinate titer, PCC 7942 cells cultured in shake flasks to stationary 
phase (OD73 ≈ 2.0) were centrifuged, and resuspended in 20 ml nitrate‑free BG‑11 medium. After centrifugation, the cells were resuspended in 
40 ml nitrate‑deplete (0×N) BG‑11 medium containing Km/Cm and cultured in shake flasks. The WT cells were cultured in the nitrate‑deplete (0×N) 
BG‑11 or BG‑11 (nitrate‑replete) (1×N) medium
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multiple copies of chromosomes and foreign genes need 
to be integrated and selected, hence making it much 
more labor-intensive and time-consuming to establish 
the CRISPRi system in cyanobacteria. To our best knowl-
edge, only 2 very recent studies have employed CRISPRi 
to engineer cyanobacteria [7, 27]. Yao et  al. explored 
CRISPRi in Synechcocystis sp. PCC 6803 to repress for-
mation of carbon storage compounds polyhydroxybutry-
ate and glycogen during nitrogen starvation [27]. Gordon 
et  al. established the CRISPRi system in Synechococcus 
sp. PCC 7002 to repress synthesis of carboxysome essen-
tial for CO2 concentrating mechanism and downregulate 
a key node in nitrogen assimilation for enhanced lactate 
production [7].
In this study, we exploited the CRISPRi system to 
modulate the gene expression in another common model 
cyanobacterium PCC 7942, which remarkably differs 
from PCC 6803 and PCC 7002 in many aspects such as 
positions in the phylogenetic tree, genome size, chromo-
some copy number, doubling time and growth conditions 
[49]. To test the feasibility, we first screened a number of 
inducible and constitutive promoters that might function 
in PCC 7942. Based on our preliminary data (Additional 
file 1: Figures S5–S8), we selected the inducible promoter 
Psmt with lowest leaky expression and highest induction 
ratio to drive the dCas9 expression, as well as constitutive 
promoters PconII and PJ23119 to drive the eyfp and sgRNA 
expression, respectively (Fig.  1a, b). Notably, even with-
out the addition of inducer, the dCas9/sgRNA still sup-
pressed the EYFP expression (Fig. 1c, d). In accord with 
our observations, Yao et al. employed a panel of PL pro-
moters to drive the dCas9 expression, which however, 
remarkably repressed the GFP expression in the absence 
of inducer [27]. Likewise, Gordon et  al. employed an 
anhydrotetracycline (aTc)-inducible promoter to drive 
dCas9 expression and observed significant EYFP repres-
sion in the uninduced state [7]. These findings altogether 
indicate that leaky expression of dCas9 triggers robust 
gene perturbation and suggest that a low dCas9 level suf-
fices to mediate CRISPRi-guided suppression.
Such leaky dCas9 expression gave rise to persistent 
EYFP knockdown (Fig.  2a) without appreciable nega-
tive effect on PCC 7942 growth (Fig. 2b), indicating that 
low level of dCas9 and continued expression of sgRNA 
do not compromise the health of PCC 7942. This attrib-
ute is desirable if the target gene is non-essential for 
cell growth/metabolism, because such persistent gene 
repression will obviate the need to add the inducer and 
save the cost in subsequent large-scale production pro-
cess. However, if mitigating the target gene expression 
is detrimental to cell growth and function, an inducible 
promoter capable of stringent control is necessary. With 
this regard, Yao et al. have identified a tightly repressed 
promoter PL22 in PCC 6803 that allowed for efficient 
induction of dCas9 expression with minimal leaky dCas9 
expression [27]. Conversely, Gordon et al. engineered the 
ribosome binding site (RBS) with reduced translation 
initiation efficiency so as to attenuate the leaky dCas9 
expression in PCC 7002. Furthermore, a suite of homolo-
gous and heterologous inducible promoters (e.g. PidiA, 
PisiAB, PetE, PnrsB, etc.) have been developed/explored for 
their applicability in cyanobacteria [1, 31, 49, 50]. Future 
studies will be directed towards developing synthetic 
parts/circuits for tightly regulatable dCas9 expression 
and robust sgRNA expression in PCC 7942.
Meanwhile, here we designed sgRNA to target different 
regions of eyfp cassette and observed that targeting the 
regions near -35 of the promoter (P1) and the non-tem-
plate coding sequence near the transcription start site 
(TSS) (NT1 and NT2) give rise to effective expression 
suppression. The data suggested that targeting the pro-
moter and a region as close to the TSS as possible gave 
better suppression, which agreed well with the sgRNA 
design rule proposed previously for E. coli [22] and 
cyanobacteria PCC 6803 [27].
Given the successful repression of exogenous reporter 
gene, we further employed the same sgRNA design rule 
to selectively knockdown genes essential for glycogen 
accumulation (glgc) and succinate conversion to fumarate 
(sdhA and sdhB) (Fig. 3). Our data demonstrated success-
ful downregulation of these genes using a single sgRNA 
targeting the coding regions, with sgRNA closer to the 
TSS resulting in more effective suppression (Fig.  4). In 
particular, repressing glgc using the glgc1 sgRNA effec-
tively suppressed the glycogen accumulation (Fig.  5a) 
and ameliorated the succinate production titer (Fig. 5b). 
Conversely, glgc2 sgRNA, which targeted a region further 
downstream of the TSS gave rise to less effective glycogen 
accumulation and succinate production (Fig.  5). Like-
wise, repressing sdhA with different sgRNAs (sdhA1 and 
sdhA2) led to quite different degrees of sdhA downregu-
lation (Fig. 4b) and sdhA1 conferred more effective sdhA 
suppression and higher succinate production (Figs.  4b, 
5b). Conversely, suppressing sdhB with two different sgR-
NAs (sdhB1 and sdhB2) gave similar degrees of sdhB sup-
pression and enhanced succinate production (Fig.  5b). 
These data altogether confirmed that CRISPRi is able to 
effectively and precisely suppress the target gene expres-
sion and re-direct carbon flux to the desired metabolic 
product, with positive correlation between the degrees 
of gene repression and succinate titer. Furthermore, the 
selected target gene and binding site could profoundly 
influence the outcome, hence underlining the importance 
of the sgRNA design.
Successful application of CRISPRi in PCC 7942 for 
gene knockdown is desirable, because PCC 7942 has 
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been genetically engineered to divert native metabolic 
pathways for product formation [1, 2]. Traditional engi-
neering approach involves the knockout of chromosomal 
genes, yet the oligoploidy nature of PCC 7942 makes it 
difficult to knockout the endogenous gene(s) on all chro-
mosomes at once, hence necessitating time-consuming 
re-streaking and antibiotic selection. Moreover, knockout 
of certain genes essential for cell metabolism, survival 
and/or proper function will impair the ability of the cells 
to produce the desired product. CRISPRi offers the flex-
ibility to fine-tune the endogenous gene expression levels 
without completely abrogating the gene functions, hence 
representing a valuable tool kit to intricately regulate the 
metabolic flux in the cells. Since CRISPRi can be used for 
genetic screen with appropriate sgRNA library design 
[25, 45], CRISPRi also may provide a promising tool to 
interrogate the functions of genes crucial for cell metabo-
lism and product production in PCC 7942.
Conclusions
In summary, we demonstrated successful CRISPRi-
mediated modulation of gene expression in the cyano-
bacterium S. elongatus PCC 7942. By appropriate sgRNA 
design, we were able to selectively knockdown exog-
enous reporter gene (eyfp) and endogenous genes (glgc, 
sdhA and sdhB). Targeted suppression of the endogenous 
genes involved in succinate synthesis increased the suc-
cinate production, with the product titer positively cor-
relating with the degrees of gene suppression. These data 
demonstrated that CRISPRi enabled customizable RNA-
guided, targeted gene suppression, which allowed for re-
directing the cellular carbon flow. This study thus paves 
a new avenue to rationally fine-tune the metabolic path-
ways in PCC 7942 for the production of biotechnological 
products.
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